Dendreon

Dendreon: The Big Push on Provenge Begins
Seeking Alpha
Tue, 02/22/11 - 12:54 pm
Provenge
Dendreon
vaccines
prostate cancer
Why The New Dendreon Analysis Does Matter — And Why It Doesn’t
Forbes
Sat, 02/19/11 - 11:39 am
Provenge
prostate cancer
Dendreon
Dendreon Adds Ammo to Provenge Defense
Minyanville
Sat, 02/19/11 - 11:13 am
Dendreon
Provenge
Top Biotech Takeout Targets in 2011
Minyanville
Fri, 02/18/11 - 03:32 pm
M&A
biotech
Biogen Idec
Human Genome
Seattle Genetics
GSK
Dendreon
Actelion
Biomarin
Exelixis
Vertex Pharmaceuticals
Celgene
Alexion
Shire
InterMune
Lexicon Pharmaceuticals
Savient
Merck KGaA
Investors scour biotechs in search of the next big payoff
Fierce Biotech
Fri, 02/18/11 - 09:40 am
investors
biotech
Dendreon
Human Genome Sciences
Biomarin
Alexion
Good News for Dendreon's Provenge
Seeking Alpha
Fri, 02/18/11 - 09:33 am
Provenge
prostate cancer
Dendreon
vaccines
Dendreon, Teva: Benefit by Riding George Soros's Coattails
Seeking Alpha
Tue, 02/15/11 - 10:24 am
Teva Pharmaceuticals
Dendreon
George Soros
Zibotentan Stopped, Long Live Provenge (for Now)
Motley Fool
Mon, 02/7/11 - 07:27 pm
Provenge
Dendreon
zibotentan
prostate cancer
AstraZeneca
Pfizer's Newest Acquisition Target
Motley Fool
Thu, 02/3/11 - 10:33 am
Pfizer
M&A
Clinical Data
Dendreon
Amarin
Dendreon expects $529.2M from senior note sale
Yahoo/AP
Sat, 01/15/11 - 12:21 pm
Dendreon
Dendreon offering $500 million in notes
Yahoo/AP
Fri, 01/14/11 - 09:51 am
Dendreon
9 Biotech Stocks for 2011
Seeking Alpha
Fri, 01/14/11 - 09:50 am
Cepheid
Cerus
Curis
Illumina
Questcor Pharmaceuticals
CompuGen
Spectrum Pharmaceuticals
Impax
Human Genome Sciences
Vertex Pharmaceuticals
Orexigen
Dendreon
Dendreon Reports Provenge Sales, Plans for Expansion
Bloomberg
Sat, 01/8/11 - 11:50 am
Dendreon
Provenge
prostate cancer
Dendreon Bringing Provenge to Europe
TheStreet.com
Fri, 01/7/11 - 09:57 am
Provenge
Europe
Dendreon
vaccines
prostate cancer
Biotech Stock Mailbag: Best Stocks to Watch in '11
TheStreet.com
Fri, 01/7/11 - 07:21 am
Oncothyreon
Xoma
Amarin
Opexa
Human Genome
Seattle Genetics
Vertex Pharmaceuticals
Merck
Dendreon
Biogen Idec
Amgen
Pharmasset
Yet Another Group Sues Medicare Over Provenge
Pharmalot
Thu, 01/6/11 - 01:16 pm
Medicare
Provenge
Dendreon
prostate cancer
Biotech 2011 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/5/11 - 11:09 am
biotech
Celgene
Dendreon
MannKind
Vertex Pharmaceuticals
Genzyme
Ariad Pharmaceuticals
Keryx
Takeovers Vs. R&D: What Will Drive Biotech Stocks in 2011?
Seeking Alpha
Tue, 12/28/10 - 02:08 pm
R&D
biotech
M&A
Cepheid
Abbott Laboratories
Bristol-Myers Squibb
Dendreon
Elan
Biogen Idec
JNJ
King
Neurocrine
Pfizer
SPDR Biotech
Director Of Equity Research At RBC Capital Markets Covers Phase III Data For Multiple New Drugs; Find Out The Stocks That Investors Should Look At
Yahoo/Wall Street Transcript
Sat, 12/18/10 - 12:24 pm
Athenahealth
Abbott Laboratories
Beckman Coulter
Agilent
AstraZeneca
Provenge
Dendreon
Benlysta
Human Genome Sciences
Telaprevir
Vertex Pharmaceuticals
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir

Pages